Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Kunming Medical CollegeActive in the last 2 years

Dong Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5133850770. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreati… Last author DOI 10.1016/j.drup.2026.101404↗
  2. METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. Co-author DOI 10.1007/s12672-025-03393-3↗
  3. O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic ca… First author DOI 10.1186/s10020-025-01285-4↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dongyun Cun · 2 shared papers, 2025 · strength 0.49
  2. Bo Tang · 2 shared papers, 2025 · strength 0.49
  3. Renchao Zou · 2 shared papers, 2025 · strength 0.49
  4. Tao Wu · 2 shared papers, 2025 · strength 0.49
  5. Junfeng Zhang · 1 shared paper, 2026 · strength 0.26
  6. Jianyou Gu · 1 shared paper, 2026 · strength 0.26
  7. Qiuhong Wang · 1 shared paper, 2025 · strength 0.26
  8. Qiuhong Wang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.